Neuvasq Biotechnologies
Advancing neurological therapies to safeguard or rebuild CNS barriers and ameliorate neurovascular function
13 employees · est. 2021 · Belgium
VectivBio
Biotech company develops treatments for severe rare diseases, aims to become global leader with patient-centric approach.
57 employees · est. 2019 · Basel, Switzerland
VectivBio is the older company (2021 vs 2019); VectivBio is the larger of the two.
Side-by-Side Comparison
| Metric | Neuvasq Biotechnologies | VectivBio |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2019 older |
| Headquarters | ||
| Headquarters | Belgium | Basel, Switzerland |
| Employees | ||
| Employees | 13 | 57 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | Acquired |
| Total Funding | ||
| Total Funding | $20.00M | $1.29B |
| Funding Rounds | ||
| Funding Rounds | 1 | 6 |
| Services | ||
| Services | Not tracked yet | GI Treatment Advancement, Pharmaceutical Development, Patient Outcome Improvement, Research & Development |
| Target Customers | ||
| Target Customers | Not tracked yet | GI Patients, Healthcare Providers, Hospitals, Medical Researchers |
| Taxonomy | ||
| Taxonomy | Neurological Therapies, CNS Barriers, Neurovascular Function, Biotechnologies, Discovery, Development, Pioneering Therapies, Severe Neurological Conditions, Research Company | Rare Diseases, Clinical-Stage Biotech, Patient-Centric Approach, Orphan Conditions, Drug Development, Therapy Commercialization, Innovative Medicines, Spinout Company, Translational Research, Life-Changing Therapies, Severe Illnesses, Targeted Therapies, Medical Needs |
| Website | ||
| Website | neuvasq.com | vectivbio.com |
About Neuvasq Biotechnologies
NeuVasQ, a Belgium-based biotechnology and pharmaceutical startup founded in 2021, is making strides in advancing neurological therapies. With the slogan "Advancing neurological therapies to safeguard or rebuild CNS barriers and ameliorate neurovascular function," Neuvasq Biotechnologies is focused...
About VectivBio
VectivBio is a Switzerland-based clinical-stage biotech company founded in 2019, focused on developing treatments for severe rare diseases. With a clear emphasis on a patient-centric approach, their mission is to address significant unmet medical needs by developing life-changing therapies. The com...
We will tell you when either one moves
BounceWatch watches Neuvasq Biotechnologies and VectivBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Neuvasq Biotechnologie... and VectivBio — by email.
Frequently Asked Questions
Compare Neuvasq Biotechnologies with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Neuvasq Biotechnologies on 11 Sep 2024, and VectivBio on 27 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.